nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbimazole—CYP19A1—corpus luteum—testicular cancer	0.181	0.368	CbGeAlD
Carbimazole—CYP19A1—seminiferous tubule of testis—testicular cancer	0.153	0.312	CbGeAlD
Carbimazole—CYP19A1—semen—testicular cancer	0.0846	0.172	CbGeAlD
Carbimazole—TPO—testis—testicular cancer	0.0328	0.0668	CbGeAlD
Carbimazole—CYP19A1—gonad—testicular cancer	0.013	0.0264	CbGeAlD
Carbimazole—CYP19A1—female gonad—testicular cancer	0.0105	0.0215	CbGeAlD
Carbimazole—CYP19A1—testis—testicular cancer	0.00934	0.019	CbGeAlD
Carbimazole—CYP19A1—lymph node—testicular cancer	0.00677	0.0138	CbGeAlD
Carbimazole—Haemoglobin—Vinblastine—testicular cancer	0.00379	0.00745	CcSEcCtD
Carbimazole—Pancytopenia—Bleomycin—testicular cancer	0.00378	0.00742	CcSEcCtD
Carbimazole—Haemorrhage—Vinblastine—testicular cancer	0.00378	0.00741	CcSEcCtD
Carbimazole—Liver disorder—Methotrexate—testicular cancer	0.00377	0.00739	CcSEcCtD
Carbimazole—Haemolytic anaemia—Cisplatin—testicular cancer	0.00376	0.00738	CcSEcCtD
Carbimazole—Alopecia—Chlorambucil—testicular cancer	0.00364	0.00714	CcSEcCtD
Carbimazole—Bone marrow depression—Epirubicin—testicular cancer	0.00356	0.00698	CcSEcCtD
Carbimazole—Pancytopenia—Dactinomycin—testicular cancer	0.00353	0.00692	CcSEcCtD
Carbimazole—Neutropenia—Dactinomycin—testicular cancer	0.00347	0.00682	CcSEcCtD
Carbimazole—Stomatitis—Bleomycin—testicular cancer	0.00346	0.00679	CcSEcCtD
Carbimazole—Alopecia—Vinblastine—testicular cancer	0.00334	0.00655	CcSEcCtD
Carbimazole—Bone marrow depression—Doxorubicin—testicular cancer	0.00329	0.00646	CcSEcCtD
Carbimazole—Angioedema—Chlorambucil—testicular cancer	0.00328	0.00643	CcSEcCtD
Carbimazole—Pancytopenia—Ifosfamide—testicular cancer	0.00323	0.00634	CcSEcCtD
Carbimazole—Stomatitis—Dactinomycin—testicular cancer	0.00323	0.00634	CcSEcCtD
Carbimazole—Leukopenia—Chlorambucil—testicular cancer	0.00321	0.0063	CcSEcCtD
Carbimazole—Haemoglobin—Bleomycin—testicular cancer	0.0032	0.00629	CcSEcCtD
Carbimazole—Haemorrhage—Bleomycin—testicular cancer	0.00319	0.00626	CcSEcCtD
Carbimazole—Agranulocytosis—Dactinomycin—testicular cancer	0.00309	0.00607	CcSEcCtD
Carbimazole—Ill-defined disorder—Vinblastine—testicular cancer	0.00305	0.00598	CcSEcCtD
Carbimazole—Hepatitis—Dactinomycin—testicular cancer	0.00297	0.00584	CcSEcCtD
Carbimazole—Ageusia—Epirubicin—testicular cancer	0.00297	0.00582	CcSEcCtD
Carbimazole—Malaise—Vinblastine—testicular cancer	0.00296	0.00582	CcSEcCtD
Carbimazole—Stomatitis—Ifosfamide—testicular cancer	0.00296	0.00581	CcSEcCtD
Carbimazole—Leukopenia—Vinblastine—testicular cancer	0.00294	0.00577	CcSEcCtD
Carbimazole—Infection—Chlorambucil—testicular cancer	0.00291	0.00571	CcSEcCtD
Carbimazole—Thrombocytopenia—Chlorambucil—testicular cancer	0.00287	0.00562	CcSEcCtD
Carbimazole—Agranulocytosis—Ifosfamide—testicular cancer	0.00283	0.00556	CcSEcCtD
Carbimazole—Alopecia—Bleomycin—testicular cancer	0.00282	0.00553	CcSEcCtD
Carbimazole—Pancytopenia—Cisplatin—testicular cancer	0.00279	0.00547	CcSEcCtD
Carbimazole—Discomfort—Vinblastine—testicular cancer	0.00276	0.00542	CcSEcCtD
Carbimazole—Ageusia—Doxorubicin—testicular cancer	0.00274	0.00538	CcSEcCtD
Carbimazole—Haemoglobin—Ifosfamide—testicular cancer	0.00274	0.00537	CcSEcCtD
Carbimazole—Jaundice cholestatic—Epirubicin—testicular cancer	0.00273	0.00537	CcSEcCtD
Carbimazole—Haemorrhage—Ifosfamide—testicular cancer	0.00272	0.00535	CcSEcCtD
Carbimazole—Hepatitis—Ifosfamide—testicular cancer	0.00272	0.00535	CcSEcCtD
Carbimazole—Alopecia—Dactinomycin—testicular cancer	0.00263	0.00516	CcSEcCtD
Carbimazole—Thrombocytopenia—Vinblastine—testicular cancer	0.00263	0.00515	CcSEcCtD
Carbimazole—Ill-defined disorder—Bleomycin—testicular cancer	0.00258	0.00505	CcSEcCtD
Carbimazole—Pancytopenia—Etoposide—testicular cancer	0.00255	0.00501	CcSEcCtD
Carbimazole—Stomatitis—Cisplatin—testicular cancer	0.00255	0.00501	CcSEcCtD
Carbimazole—Jaundice cholestatic—Doxorubicin—testicular cancer	0.00253	0.00496	CcSEcCtD
Carbimazole—Neutropenia—Etoposide—testicular cancer	0.00251	0.00493	CcSEcCtD
Carbimazole—Malaise—Bleomycin—testicular cancer	0.0025	0.00491	CcSEcCtD
Carbimazole—Leukopenia—Bleomycin—testicular cancer	0.00248	0.00488	CcSEcCtD
Carbimazole—Angiopathy—Ifosfamide—testicular cancer	0.00247	0.00485	CcSEcCtD
Carbimazole—Feeling abnormal—Chlorambucil—testicular cancer	0.00241	0.00473	CcSEcCtD
Carbimazole—Aplastic anaemia—Methotrexate—testicular cancer	0.00241	0.00473	CcSEcCtD
Carbimazole—Alopecia—Ifosfamide—testicular cancer	0.00241	0.00473	CcSEcCtD
Carbimazole—Hepatocellular injury—Epirubicin—testicular cancer	0.0024	0.00471	CcSEcCtD
Carbimazole—Ill-defined disorder—Dactinomycin—testicular cancer	0.0024	0.00471	CcSEcCtD
Carbimazole—Myalgia—Bleomycin—testicular cancer	0.00236	0.00464	CcSEcCtD
Carbimazole—Jaundice—Etoposide—testicular cancer	0.00234	0.00459	CcSEcCtD
Carbimazole—Stomatitis—Etoposide—testicular cancer	0.00234	0.00459	CcSEcCtD
Carbimazole—Discomfort—Bleomycin—testicular cancer	0.00233	0.00458	CcSEcCtD
Carbimazole—Malaise—Dactinomycin—testicular cancer	0.00233	0.00458	CcSEcCtD
Carbimazole—Urticaria—Chlorambucil—testicular cancer	0.00233	0.00456	CcSEcCtD
Carbimazole—Mouth ulceration—Methotrexate—testicular cancer	0.00232	0.00455	CcSEcCtD
Carbimazole—Leukopenia—Dactinomycin—testicular cancer	0.00232	0.00455	CcSEcCtD
Carbimazole—Body temperature increased—Chlorambucil—testicular cancer	0.00231	0.00454	CcSEcCtD
Carbimazole—Aplastic anaemia—Epirubicin—testicular cancer	0.00226	0.00443	CcSEcCtD
Carbimazole—Infection—Bleomycin—testicular cancer	0.00225	0.00442	CcSEcCtD
Carbimazole—Agranulocytosis—Etoposide—testicular cancer	0.00224	0.00439	CcSEcCtD
Carbimazole—Hepatocellular injury—Doxorubicin—testicular cancer	0.00222	0.00436	CcSEcCtD
Carbimazole—Thrombocytopenia—Bleomycin—testicular cancer	0.00222	0.00435	CcSEcCtD
Carbimazole—Feeling abnormal—Vinblastine—testicular cancer	0.00221	0.00434	CcSEcCtD
Carbimazole—Myalgia—Dactinomycin—testicular cancer	0.0022	0.00432	CcSEcCtD
Carbimazole—Ill-defined disorder—Ifosfamide—testicular cancer	0.0022	0.00432	CcSEcCtD
Carbimazole—Discomfort—Dactinomycin—testicular cancer	0.00218	0.00427	CcSEcCtD
Carbimazole—Mouth ulceration—Epirubicin—testicular cancer	0.00217	0.00426	CcSEcCtD
Carbimazole—Angioedema—Ifosfamide—testicular cancer	0.00217	0.00425	CcSEcCtD
Carbimazole—Hypersensitivity—Chlorambucil—testicular cancer	0.00216	0.00423	CcSEcCtD
Carbimazole—Malaise—Ifosfamide—testicular cancer	0.00214	0.0042	CcSEcCtD
Carbimazole—Leukopenia—Ifosfamide—testicular cancer	0.00212	0.00417	CcSEcCtD
Carbimazole—Infection—Dactinomycin—testicular cancer	0.0021	0.00412	CcSEcCtD
Carbimazole—Aplastic anaemia—Doxorubicin—testicular cancer	0.00209	0.0041	CcSEcCtD
Carbimazole—Alopecia—Cisplatin—testicular cancer	0.00208	0.00407	CcSEcCtD
Carbimazole—Pruritus—Chlorambucil—testicular cancer	0.00207	0.00406	CcSEcCtD
Carbimazole—Thrombocytopenia—Dactinomycin—testicular cancer	0.00207	0.00406	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.00206	0.00405	CcSEcCtD
Carbimazole—Arthralgia—Ifosfamide—testicular cancer	0.00202	0.00396	CcSEcCtD
Carbimazole—Myalgia—Ifosfamide—testicular cancer	0.00202	0.00396	CcSEcCtD
Carbimazole—Mouth ulceration—Doxorubicin—testicular cancer	0.00201	0.00394	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.00201	0.00394	CcSEcCtD
Carbimazole—Discomfort—Ifosfamide—testicular cancer	0.002	0.00392	CcSEcCtD
Carbimazole—Hypersensitivity—Vinblastine—testicular cancer	0.00198	0.00388	CcSEcCtD
Carbimazole—Angiopathy—Etoposide—testicular cancer	0.00195	0.00383	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.00192	0.00378	CcSEcCtD
Carbimazole—Infection—Ifosfamide—testicular cancer	0.00192	0.00377	CcSEcCtD
Carbimazole—Alopecia—Etoposide—testicular cancer	0.0019	0.00373	CcSEcCtD
Carbimazole—Nervous system disorder—Ifosfamide—testicular cancer	0.0019	0.00373	CcSEcCtD
Carbimazole—Ill-defined disorder—Cisplatin—testicular cancer	0.0019	0.00372	CcSEcCtD
Carbimazole—Thrombocytopenia—Ifosfamide—testicular cancer	0.0019	0.00372	CcSEcCtD
Carbimazole—Skin disorder—Ifosfamide—testicular cancer	0.00188	0.00369	CcSEcCtD
Carbimazole—Feeling abnormal—Bleomycin—testicular cancer	0.00187	0.00366	CcSEcCtD
Carbimazole—Malaise—Cisplatin—testicular cancer	0.00184	0.00362	CcSEcCtD
Carbimazole—Leukopenia—Cisplatin—testicular cancer	0.00183	0.00359	CcSEcCtD
Carbimazole—Urticaria—Bleomycin—testicular cancer	0.0018	0.00353	CcSEcCtD
Carbimazole—Body temperature increased—Bleomycin—testicular cancer	0.00179	0.00351	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.00176	0.00346	CcSEcCtD
Carbimazole—Myalgia—Cisplatin—testicular cancer	0.00174	0.00342	CcSEcCtD
Carbimazole—Feeling abnormal—Dactinomycin—testicular cancer	0.00174	0.00342	CcSEcCtD
Carbimazole—Nausea—Chlorambucil—testicular cancer	0.00174	0.00341	CcSEcCtD
Carbimazole—Ill-defined disorder—Etoposide—testicular cancer	0.00174	0.00341	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.00173	0.00339	CcSEcCtD
Carbimazole—Liver function test abnormal—Methotrexate—testicular cancer	0.00172	0.00338	CcSEcCtD
Carbimazole—Discomfort—Cisplatin—testicular cancer	0.00172	0.00338	CcSEcCtD
Carbimazole—Malaise—Etoposide—testicular cancer	0.00169	0.00332	CcSEcCtD
Carbimazole—Headache—Vinblastine—testicular cancer	0.00168	0.0033	CcSEcCtD
Carbimazole—Leukopenia—Etoposide—testicular cancer	0.00168	0.00329	CcSEcCtD
Carbimazole—Body temperature increased—Dactinomycin—testicular cancer	0.00167	0.00328	CcSEcCtD
Carbimazole—Hypersensitivity—Bleomycin—testicular cancer	0.00167	0.00328	CcSEcCtD
Carbimazole—Infection—Cisplatin—testicular cancer	0.00166	0.00325	CcSEcCtD
Carbimazole—Nervous system disorder—Cisplatin—testicular cancer	0.00164	0.00321	CcSEcCtD
Carbimazole—Thrombocytopenia—Cisplatin—testicular cancer	0.00163	0.00321	CcSEcCtD
Carbimazole—Skin disorder—Cisplatin—testicular cancer	0.00162	0.00318	CcSEcCtD
Carbimazole—Liver function test abnormal—Epirubicin—testicular cancer	0.00161	0.00316	CcSEcCtD
Carbimazole—Pruritus—Bleomycin—testicular cancer	0.0016	0.00315	CcSEcCtD
Carbimazole—Feeling abnormal—Ifosfamide—testicular cancer	0.0016	0.00313	CcSEcCtD
Carbimazole—Eosinophilia—Methotrexate—testicular cancer	0.00159	0.00313	CcSEcCtD
Carbimazole—Nausea—Vinblastine—testicular cancer	0.00159	0.00313	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00158	0.00311	CcSEcCtD
Carbimazole—Discomfort—Etoposide—testicular cancer	0.00158	0.00309	CcSEcCtD
Carbimazole—Hypersensitivity—Dactinomycin—testicular cancer	0.00156	0.00305	CcSEcCtD
Carbimazole—Urticaria—Ifosfamide—testicular cancer	0.00154	0.00302	CcSEcCtD
Carbimazole—Body temperature increased—Ifosfamide—testicular cancer	0.00153	0.003	CcSEcCtD
Carbimazole—Pancytopenia—Methotrexate—testicular cancer	0.00153	0.003	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00152	0.00298	CcSEcCtD
Carbimazole—Infection—Etoposide—testicular cancer	0.00152	0.00298	CcSEcCtD
Carbimazole—Neutropenia—Methotrexate—testicular cancer	0.00151	0.00296	CcSEcCtD
Carbimazole—Thrombocytopenia—Etoposide—testicular cancer	0.0015	0.00294	CcSEcCtD
Carbimazole—Eosinophilia—Epirubicin—testicular cancer	0.00149	0.00293	CcSEcCtD
Carbimazole—Liver function test abnormal—Doxorubicin—testicular cancer	0.00149	0.00292	CcSEcCtD
Carbimazole—Skin disorder—Etoposide—testicular cancer	0.00149	0.00291	CcSEcCtD
Carbimazole—Pancytopenia—Epirubicin—testicular cancer	0.00143	0.00281	CcSEcCtD
Carbimazole—Rash—Bleomycin—testicular cancer	0.00143	0.0028	CcSEcCtD
Carbimazole—Dermatitis—Bleomycin—testicular cancer	0.00143	0.0028	CcSEcCtD
Carbimazole—Hypersensitivity—Ifosfamide—testicular cancer	0.00143	0.0028	CcSEcCtD
Carbimazole—Neutropenia—Epirubicin—testicular cancer	0.00141	0.00277	CcSEcCtD
Carbimazole—Stomatitis—Methotrexate—testicular cancer	0.0014	0.00275	CcSEcCtD
Carbimazole—Eosinophilia—Doxorubicin—testicular cancer	0.00138	0.00271	CcSEcCtD
Carbimazole—Feeling abnormal—Cisplatin—testicular cancer	0.00138	0.0027	CcSEcCtD
Carbimazole—Pruritus—Ifosfamide—testicular cancer	0.00137	0.00269	CcSEcCtD
Carbimazole—Nausea—Bleomycin—testicular cancer	0.00135	0.00264	CcSEcCtD
Carbimazole—Agranulocytosis—Methotrexate—testicular cancer	0.00134	0.00263	CcSEcCtD
Carbimazole—Rash—Dactinomycin—testicular cancer	0.00133	0.00261	CcSEcCtD
Carbimazole—Pancytopenia—Doxorubicin—testicular cancer	0.00132	0.0026	CcSEcCtD
Carbimazole—Body temperature increased—Cisplatin—testicular cancer	0.00132	0.00259	CcSEcCtD
Carbimazole—Stomatitis—Epirubicin—testicular cancer	0.00131	0.00257	CcSEcCtD
Carbimazole—Jaundice—Epirubicin—testicular cancer	0.00131	0.00257	CcSEcCtD
Carbimazole—Neutropenia—Doxorubicin—testicular cancer	0.0013	0.00256	CcSEcCtD
Carbimazole—Haemoglobin—Methotrexate—testicular cancer	0.0013	0.00254	CcSEcCtD
Carbimazole—Haemorrhage—Methotrexate—testicular cancer	0.00129	0.00253	CcSEcCtD
Carbimazole—Hepatitis—Methotrexate—testicular cancer	0.00129	0.00253	CcSEcCtD
Carbimazole—Feeling abnormal—Etoposide—testicular cancer	0.00126	0.00247	CcSEcCtD
Carbimazole—Nausea—Dactinomycin—testicular cancer	0.00125	0.00246	CcSEcCtD
Carbimazole—Agranulocytosis—Epirubicin—testicular cancer	0.00125	0.00246	CcSEcCtD
Carbimazole—Hypersensitivity—Cisplatin—testicular cancer	0.00123	0.00241	CcSEcCtD
Carbimazole—Rash—Ifosfamide—testicular cancer	0.00122	0.0024	CcSEcCtD
Carbimazole—Dermatitis—Ifosfamide—testicular cancer	0.00122	0.00239	CcSEcCtD
Carbimazole—Urticaria—Etoposide—testicular cancer	0.00121	0.00238	CcSEcCtD
Carbimazole—Haemoglobin—Epirubicin—testicular cancer	0.00121	0.00238	CcSEcCtD
Carbimazole—Jaundice—Doxorubicin—testicular cancer	0.00121	0.00238	CcSEcCtD
Carbimazole—Stomatitis—Doxorubicin—testicular cancer	0.00121	0.00238	CcSEcCtD
Carbimazole—Body temperature increased—Etoposide—testicular cancer	0.00121	0.00237	CcSEcCtD
Carbimazole—Hepatitis—Epirubicin—testicular cancer	0.00121	0.00237	CcSEcCtD
Carbimazole—Haemorrhage—Epirubicin—testicular cancer	0.00121	0.00237	CcSEcCtD
Carbimazole—Angiopathy—Methotrexate—testicular cancer	0.00117	0.0023	CcSEcCtD
Carbimazole—Agranulocytosis—Doxorubicin—testicular cancer	0.00116	0.00228	CcSEcCtD
Carbimazole—Nausea—Ifosfamide—testicular cancer	0.00115	0.00226	CcSEcCtD
Carbimazole—Alopecia—Methotrexate—testicular cancer	0.00114	0.00224	CcSEcCtD
Carbimazole—Hypersensitivity—Etoposide—testicular cancer	0.00113	0.00221	CcSEcCtD
Carbimazole—Haemoglobin—Doxorubicin—testicular cancer	0.00112	0.0022	CcSEcCtD
Carbimazole—Haemorrhage—Doxorubicin—testicular cancer	0.00112	0.00219	CcSEcCtD
Carbimazole—Hepatitis—Doxorubicin—testicular cancer	0.00112	0.00219	CcSEcCtD
Carbimazole—Angiopathy—Epirubicin—testicular cancer	0.00109	0.00215	CcSEcCtD
Carbimazole—Pruritus—Etoposide—testicular cancer	0.00108	0.00212	CcSEcCtD
Carbimazole—Alopecia—Epirubicin—testicular cancer	0.00107	0.00209	CcSEcCtD
Carbimazole—Rash—Cisplatin—testicular cancer	0.00105	0.00207	CcSEcCtD
Carbimazole—Dermatitis—Cisplatin—testicular cancer	0.00105	0.00206	CcSEcCtD
Carbimazole—Ill-defined disorder—Methotrexate—testicular cancer	0.00104	0.00204	CcSEcCtD
Carbimazole—Angiopathy—Doxorubicin—testicular cancer	0.00101	0.00199	CcSEcCtD
Carbimazole—Malaise—Methotrexate—testicular cancer	0.00101	0.00199	CcSEcCtD
Carbimazole—Leukopenia—Methotrexate—testicular cancer	0.001	0.00197	CcSEcCtD
Carbimazole—Nausea—Cisplatin—testicular cancer	0.000991	0.00195	CcSEcCtD
Carbimazole—Alopecia—Doxorubicin—testicular cancer	0.000986	0.00194	CcSEcCtD
Carbimazole—Ill-defined disorder—Epirubicin—testicular cancer	0.000974	0.00191	CcSEcCtD
Carbimazole—Rash—Etoposide—testicular cancer	0.000964	0.00189	CcSEcCtD
Carbimazole—Dermatitis—Etoposide—testicular cancer	0.000963	0.00189	CcSEcCtD
Carbimazole—Headache—Etoposide—testicular cancer	0.000958	0.00188	CcSEcCtD
Carbimazole—Arthralgia—Methotrexate—testicular cancer	0.000955	0.00187	CcSEcCtD
Carbimazole—Myalgia—Methotrexate—testicular cancer	0.000955	0.00187	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000949	0.00186	CcSEcCtD
Carbimazole—Malaise—Epirubicin—testicular cancer	0.000947	0.00186	CcSEcCtD
Carbimazole—Discomfort—Methotrexate—testicular cancer	0.000944	0.00185	CcSEcCtD
Carbimazole—Leukopenia—Epirubicin—testicular cancer	0.00094	0.00184	CcSEcCtD
Carbimazole—Infection—Methotrexate—testicular cancer	0.00091	0.00179	CcSEcCtD
Carbimazole—Nausea—Etoposide—testicular cancer	0.000908	0.00178	CcSEcCtD
Carbimazole—Ill-defined disorder—Doxorubicin—testicular cancer	0.000902	0.00177	CcSEcCtD
Carbimazole—Nervous system disorder—Methotrexate—testicular cancer	0.000898	0.00176	CcSEcCtD
Carbimazole—Thrombocytopenia—Methotrexate—testicular cancer	0.000897	0.00176	CcSEcCtD
Carbimazole—Arthralgia—Epirubicin—testicular cancer	0.000894	0.00175	CcSEcCtD
Carbimazole—Myalgia—Epirubicin—testicular cancer	0.000894	0.00175	CcSEcCtD
Carbimazole—Skin disorder—Methotrexate—testicular cancer	0.00089	0.00175	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000888	0.00174	CcSEcCtD
Carbimazole—Discomfort—Epirubicin—testicular cancer	0.000883	0.00173	CcSEcCtD
Carbimazole—Malaise—Doxorubicin—testicular cancer	0.000876	0.00172	CcSEcCtD
Carbimazole—Leukopenia—Doxorubicin—testicular cancer	0.00087	0.00171	CcSEcCtD
Carbimazole—Infection—Epirubicin—testicular cancer	0.000851	0.00167	CcSEcCtD
Carbimazole—Nervous system disorder—Epirubicin—testicular cancer	0.000841	0.00165	CcSEcCtD
Carbimazole—Thrombocytopenia—Epirubicin—testicular cancer	0.000839	0.00165	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000834	0.00164	CcSEcCtD
Carbimazole—Skin disorder—Epirubicin—testicular cancer	0.000833	0.00163	CcSEcCtD
Carbimazole—Arthralgia—Doxorubicin—testicular cancer	0.000827	0.00162	CcSEcCtD
Carbimazole—Myalgia—Doxorubicin—testicular cancer	0.000827	0.00162	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000822	0.00161	CcSEcCtD
Carbimazole—Discomfort—Doxorubicin—testicular cancer	0.000817	0.0016	CcSEcCtD
Carbimazole—Infection—Doxorubicin—testicular cancer	0.000788	0.00155	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000781	0.00153	CcSEcCtD
Carbimazole—Nervous system disorder—Doxorubicin—testicular cancer	0.000778	0.00153	CcSEcCtD
Carbimazole—Thrombocytopenia—Doxorubicin—testicular cancer	0.000776	0.00152	CcSEcCtD
Carbimazole—Skin disorder—Doxorubicin—testicular cancer	0.00077	0.00151	CcSEcCtD
Carbimazole—Feeling abnormal—Methotrexate—testicular cancer	0.000755	0.00148	CcSEcCtD
Carbimazole—Urticaria—Methotrexate—testicular cancer	0.000728	0.00143	CcSEcCtD
Carbimazole—Body temperature increased—Methotrexate—testicular cancer	0.000724	0.00142	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000723	0.00142	CcSEcCtD
Carbimazole—Feeling abnormal—Epirubicin—testicular cancer	0.000706	0.00139	CcSEcCtD
Carbimazole—Urticaria—Epirubicin—testicular cancer	0.000681	0.00134	CcSEcCtD
Carbimazole—Body temperature increased—Epirubicin—testicular cancer	0.000678	0.00133	CcSEcCtD
Carbimazole—Hypersensitivity—Methotrexate—testicular cancer	0.000675	0.00132	CcSEcCtD
Carbimazole—Feeling abnormal—Doxorubicin—testicular cancer	0.000654	0.00128	CcSEcCtD
Carbimazole—Pruritus—Methotrexate—testicular cancer	0.000648	0.00127	CcSEcCtD
Carbimazole—Hypersensitivity—Epirubicin—testicular cancer	0.000631	0.00124	CcSEcCtD
Carbimazole—Urticaria—Doxorubicin—testicular cancer	0.00063	0.00124	CcSEcCtD
Carbimazole—Body temperature increased—Doxorubicin—testicular cancer	0.000627	0.00123	CcSEcCtD
Carbimazole—Pruritus—Epirubicin—testicular cancer	0.000606	0.00119	CcSEcCtD
Carbimazole—Hypersensitivity—Doxorubicin—testicular cancer	0.000584	0.00115	CcSEcCtD
Carbimazole—Rash—Methotrexate—testicular cancer	0.000577	0.00113	CcSEcCtD
Carbimazole—Dermatitis—Methotrexate—testicular cancer	0.000577	0.00113	CcSEcCtD
Carbimazole—Headache—Methotrexate—testicular cancer	0.000574	0.00113	CcSEcCtD
Carbimazole—Pruritus—Doxorubicin—testicular cancer	0.000561	0.0011	CcSEcCtD
Carbimazole—Nausea—Methotrexate—testicular cancer	0.000544	0.00107	CcSEcCtD
Carbimazole—Rash—Epirubicin—testicular cancer	0.00054	0.00106	CcSEcCtD
Carbimazole—Dermatitis—Epirubicin—testicular cancer	0.00054	0.00106	CcSEcCtD
Carbimazole—Headache—Epirubicin—testicular cancer	0.000537	0.00105	CcSEcCtD
Carbimazole—Nausea—Epirubicin—testicular cancer	0.000509	0.000999	CcSEcCtD
Carbimazole—Rash—Doxorubicin—testicular cancer	0.0005	0.000981	CcSEcCtD
Carbimazole—Dermatitis—Doxorubicin—testicular cancer	0.0005	0.00098	CcSEcCtD
Carbimazole—Headache—Doxorubicin—testicular cancer	0.000497	0.000975	CcSEcCtD
Carbimazole—Nausea—Doxorubicin—testicular cancer	0.000471	0.000924	CcSEcCtD
